Strumento inattivo

Azioni AXIOGENES

Azioni

Prezzo di chiusura Xetra Altri mercati azionari
- ^EUR	-

Axiogenes : s : und GE Healthcare unterzeichnen Sub-Lizenzvertrag über Patente für zelluläre Testsysteme	16/07/15
Axiogenes : s : Signs Sublicensing Agreement for Cellular Assay Patents with GE Healthcare.	14/07/15
AXIOGENES : Axiogenesis Earns U.S. Patent with In Vitro Drug Discovery Assay for Hypertrophic Cardiomyopathy	04/12/12
AXIOGENES : At Last, a Cardiomyopathy Disease Model: Axiogenesis Has Been Granted a Far-Reaching Patent in Europe	10/10/11

Settore

	Variaz. 1 gen.	Capi.
MODERNA, INC.	+38,36%	52,73 Mrd
LONZA GROUP AG	+39,67%	39 Mrd
IQVIA HOLDINGS INC.	-8,63%	38,52 Mrd
ALNYLAM PHARMACEUTICALS, INC.	+25,46%	30,38 Mrd
CELLTRION, INC.	-11,17%	26,39 Mrd
ICON PUBLIC LIMITED COMPANY	+11,44%	26,08 Mrd
UNITED THERAPEUTICS CORPORATION	+45,09%	14,15 Mrd
MEDPACE HOLDINGS, INC.	+32,93%	12,6 Mrd
BIO-TECHNE CORPORATION	-5,30%	11,51 Mrd